Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
NanoviricidesNNVC -1.88%34 3-Year EBITDA Growth Rate is 3.40% as of Mar. 2026, which is at its 10-year median of 3.40. GuruFocus rates NNVC with a GF Score™ of 34/100. Among 1,137 Biotechnology companies, Nanoviricides ranks worse than 64.82% on this metric.
During the past 3 years, the average EBITDA Per Share Growth Rate was 3.40% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was 18.70% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Nanoviricides was 33.30% per year. The lowest was -230.50% per year. And the median was 3.40% per year.
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Nanoviricides 3-Year EBITDA Growth Rate Related Terms
NNVC vs LSTA, SGMO, LITS: 3-Year EBITDA Growth Rate Comparison
For the Biotechnology subindustry, Nanoviricides's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nanoviricides 3-Year EBITDA Growth Rate vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Nanoviricides's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Nanoviricides's 3-Year EBITDA Growth Rate falls into.
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 3.40% mean?
Nanoviricides (NNVC) has a 3-Year EBITDA Growth Rate of 3.40% as of Mar. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Nanoviricides and its competitors. This is near median its historical median of 3.40. According to the industry distribution chart, Nanoviricides ranks #737 out of 1137 companies in the Biotechnology industry, placing it in the top 64.8%.
Is Nanoviricides' 3-Year EBITDA Growth Rate too high?
Nanoviricides' current 3-Year EBITDA Growth Rate of 3.40% is near median its 10-year median of 3.40. The Biotechnology industry median 3-Year EBITDA Growth Rate is 14.80. Nanoviricides' value of 3.40% is 77% below this industry median. Based on the distribution chart, Nanoviricides ranks #737 out of 1137 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Nanoviricides has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Nanoviricides' 3-Year EBITDA Growth Rate compare to LSTA and SGMO?
According to the Biotechnology industry distribution chart, Nanoviricides ranks #737 out of 1137 companies for 3-Year EBITDA Growth Rate. This places Nanoviricides in the lower half of its industry. The industry median 3-Year EBITDA Growth Rate is 14.80. Nanoviricides' value of 3.40% is 77% below this benchmark. While the company's 10-year median is 3.40 vs. the industry median of 14.80, Nanoviricides has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Biotechnology company?
The median 3-Year EBITDA Growth Rate among Biotechnology companies is 14.80, based on 1,137 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nanoviricides's current 3-Year EBITDA Growth Rate of 3.40% is 77% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Nanoviricides and its competitors. For the Biotechnology industry, the median 3-Year EBITDA Growth Rate is 14.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nanoviricides's current 3-Year EBITDA Growth Rate is 3.40%, which is near median its own 10-year median of 3.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nanoviricides stock overvalued right now?
Nanoviricides (NNVC) has a current 3-Year EBITDA Growth Rate of 3.40%. The current 3-Year EBITDA Growth Rate is 3.40%, which is near median its 10-year median of 3.40 and 77% below the Biotechnology industry median of 14.80. Nanoviricides' overall GF Score™ is 34/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Nanoviricides (NNVC), the current 3-Year EBITDA Growth Rate is 3.40% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.
34GF Score
Get the complete analysis for NNVC
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NNVC has been successfully added to your 
